EOLS

Evolus, Inc.

Healthcare · $528M market cap

We can't put a fair value on EOLS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth-50.5% a year✗

Sales growth42.9% a year✓

Free cash flow growth—?

Return on invested capital-26.4%✗

Follow EOLS

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 2, 2026: no open-market purchases and 1 sale worth $950K. Why purchases matter

Sales

MOATAZEDI DAVID

See Remarks · 2026-09-02

Sold

$950K

About Evolus, Inc.

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines…

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

Verdict

Business quality

Insider activity

Sales

About Evolus, Inc.